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Context: Pain beliefs as indexed by the Survey of Pain Attitudes (SOPA) have been consistently 
shown to predict pain adjustment outcomes in Western populations. However, its utility in non-
western populations is unclear.  
Objective: We evaluated the construct and predictive validity of the Chinese version of the 14-
item SOPA (ChSOPA-14) in a sample of Chinese patients with chronic pain.  
Methods: A total of 208Chinese patients with chronic musculoskeletal pain completed the 
ChSOPA-14, the Chronic Pain Grade (CPG) questionnaire, the Pain Catastrophizing Scale (PCS), 
the Centre for Epidemiological Studies-Depression Scale (CES-D), and measures of 
sociodemographic characteristics.  
Results: Except Medical Cure, all ChSOPA-14 scales were significantly correlated with validity 
criterion measures (all p<0.05) in expected directions. The present Chinese sample scored the 
highest on the Medical Cure scale (mean=2.98, SD=1.05) but the lowest on the Disability scale 
(mean=1.75, SD=1.67). Results of hierarchical multiple regression analyses showed the 
ChSOPA-14 scales predicted concurrent depression (F(7,177)=14.51, p<.001) and pain disability  
(F(7,180)=8.77, p<.001).  Pain Control (stdβ=-.13; 95% CI: -3.41, -.13; p<.05) and Emotion 
(stdβ=29; 95% CI: 1.76, 5.02; p<.001) emerged as significant independent predictors of 
concurrent depression whereas Disability (stdβ =.19, 95% CI: 1.33, 7.88, p<.01), Emotion 
(stdβ=16, 95% CI: .08, 7.59, p<.05), and Solicitude (stdβ=-.14, 95% CI: -7.05, -.04, p<.05) 
significantly associated with concurrent disability.  
Conclusion: The findings offer preliminary evidence for the construct and concurrent predictive 
validity of the ChSOPA-14. This makes available a suitable instrument for chronic pain in the 
Chinese population and will facilitate future cross-cultural research on pain beliefs.  
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INTRODUCTION   
The Survey of Pain Attitudes (SOPA) assesses beliefs about pain that are hypothesized to 
influence adjustment to pain and that are the targets of multidisciplinary pain treatment.1 The 
SOPA measures seven pain-related belief dimensions: (a) Medical Cure, (b) Pain Control, (c) 
Solicitude, (d) Disability, (e) Medication, (f) Emotion, and (g) Harm.2,3 To lower assessment 
burden, brief versions of the SOPA have been developed.4  All SOPA versions have empirical 
support for their reliability and validity.2-5  
Previous studies employing SOPA to measure pain beliefs and cognitions have shown that 
SOPA Disability, Medical Cure, Solicitude, and Control scales are associated with concurrent 
adjustment outcomes.6,7 In another study that assessed patient functioning and behavior based on 
patient report, spouse report, and direct observation, post-treatment to follow-up change in SOPA 
Disability, Harm, and Solicitude scales were found to be associated with posttreatment to follow-
up change in patient functioning scores 8. Other studies have shown that changes in SOPA scores 
after a pain education program are significantly associated with changes in physical 
functioning.9,10 
While previous research supports the hypothesized associations between SOPA scales and 
measures of patient functioning, the existing data have been obtained exclusively from Western 
populations.  The utility of the scale in non-Western pain populations has not yet been evaluated. 
In light of this, this study sought to evaluate the psychometric properties of the Chinese version 




Following ethics approval from both the university and hospital Institutional Review 
Boards, consecutive patients with chronic musculoskeletal pain attending an orthopedics 
specialist out-patient clinic of a Hong Kong public hospital were invited to participate in the 
study. Inclusion criteria included: (1) ≥18 years of age; (2) native Cantonese speakers; (3) lacking 
communication problems or physical conditions preventing completion of the study measures; (4) 
exhibiting no confusion and having no prior diagnosis of cognitive impairment from medical 
records; and (5) willing to participate in the study were approached and gave fully informed 
consent. Interviews generated information on pain and socio-demographic characteristics. Those 
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meeting chronic pain criteria (pain duration >3 months) then completed the remaining 
questionnaires while waiting for their consultation. After obtaining written consent, patients 




The 14-item Survey of Pain Attitudes (SOPA-14) 
The SOPA-141, 4 consists of 14 items assessing seven pain related beliefs including (1) 
belief in a medical cure for pain (Medical Cure), (2) belief in one’s ability to control pain (Pain 
Control), (3) belief that it is the responsibility of others to assist patients who are experiencing 
pain (Solicitude), (4) belief that the patient is disabled because of pain (Disability), (5) belief that 
medications are the best treatment strategy for pain (Medication), (6) the influence of emotions 
on pain (Emotion), and (7) belief that pain evidences physical injury (Harm). Each subscale 
consists of 2 items and patients are asked to rate on a 5-point Likert scale (0=very untrue; 4=very 
true). The Chinese version of SOPA-14 (ChSOPA-14) was translated by the first author (WSW). 
The initial Chinese version was back-translated into English by a bilingual psycholinguist. The 
back-translation (in English) was then reviewed by authors of the original English version for the 
content equivalence between the back-translation and the original versions of the SOPA. 
Discrepancies were discussed and resolved by consensus, and modifications in the translations 
were made, as needed, resulting in the penultimate version of the ChSOPA-14.  
The penultimate ChSOPA-14 items were subsequently evaluated by a panel consisting of 
11 bilingual postgraduate students. Each panel member was asked to rate the fluency and 
semantic equivalence of the Chinese translation against the original English version of SOPA-14 
items on 5-point Likert scales (1=poor, 2=fair, 3=good, 4=very good, 5=excellent). The results of 
the panel evaluation showed that 3 of the 14 items obtained a modal rating of 5, suggesting an 
excellent equivalence of the item translation. All of the remaining items had a modal rating of 4, 
indicating good equivalence of the English-Chinese translation. The penultimate ChSOPA-14 
was subsequently piloted in 10 Chinese patients attending a public hospital orthopaedics 
specialist out-patient clinic in Hong Kong. The patients indicated that the instructions and the 
items were easy to understand. The final Chinese translation of the ChSOPA-14 was prepared 
based on the results the above translation and evaluation processes.   
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Chronic Pain Grade (CPG) 
Chronic pain severity was assessed using the Chronic Pain Grade (CPG) questionnaire,11 
a seven-item instrument that measures three domains of pain severity: persistence, intensity and 
disability/interference. The three intensity items ask respondents to rate their current, average and 
worst pain intensity on 0–10 Numerical Rating Scales (NRS). A Characteristic Pain Intensity 
Score is derived by averaging the responses to the intensity items and multiplying this by 10. 
Three CPG items assess pain interference with (1) daily activities, (2) social activities, and (3) 
working ability using 0–10 NRSs. The CPG Disability Score is derived by multiplying the 
average of the three interference items by 10. Persistence is assessed in the original CPG by 
asking the respondent to indicate the number of days out of the past six months days that he/she 
was disabled by pain (although we modified this to “the past three months” because chronic pain 
is now defined as pain that persists for at least three months11).  The Disability Score and the 
number of disability days are recoded into 5-point scales and summed, yielding “Disability 
Points”. Based on the Pain Intensity Score and Disability Points, the CPG classifies respondents 
into five hierarchical grades (see Table 1). The English version of the CPG possesses good 
psychometric properties.12 The CPG was translated into Chinese language based on standard 
translation procedures and results of exploratory factor analyses showed that the CPG six items 
were grouped into 3 main dimensions: Disability, Intensity and Persistence. The Cronbach’s αs 
for the CPG Disability and Characteristic Intensity scales were .87 and .68, respectively.13 
 
Pain Catastrophizing Scale (PCS) 
Pain-related catastrophizing cognitions were assessed using the 13-item Pain 
Catastrophizing Scale (PCS).14  Respondents are asked to reflect on past painful experiences and 
to indicate the frequency with which they experienced each of 13 thoughts or feelings when 
experiencing pain on 5-point Likert scales (0=“Not at all”; 4=“All the time”). The PCS can be 
scored into three scales (Rumination, Magnification, and Helplessness) as well as a total score 
that ranges from 0 to 52. The PCS has demonstrated good internal consistency (Cronbach’s α for 
the total scale=.87), test-retest reliability at 6 weeks (r=.75), and construct validity.14 The Chinese 
PCS also showed good psychometric properties (Cronbach’s α for the total score = .93, item-total 
correlation coefficients ranging from .58 to .78).15   
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Center for Epidemiological Studies -- Depression Scale (CES-D) 
Depression was assessed using the 20-item Center for Epidemiological Studies -- 
Depression scale (CES-D).16 The CES-D was designed to assess frequency of depressive 
symptoms in non-psychiatric populations.  Respondents are asked to indicate the frequency with 
which they experience each of the 20 symptoms listed during the past week on 4-point Likert 
scales (0=“Less than one day”; 3=“5-7 days”).  The total CES-D score is computed by summing 
the responses of all items, with higher scores indicating greater depressive symptoms (score 
range: 0-60). The CES-D has demonstrated good concurrent validity with clinical diagnoses of 
depression in chronic pain populations.17,18 The Chinese version has been validated, yielding 
good internal consistency (Cronbach’s α=.77) and reliability (r=.77).19  
 
Statistical analysis 
Basic descriptive statistics were used to assess sample characteristics. Pearson’s 
correlation tests were performed to evaluate the univariate relationship between the SOPA-14 
scales and the four criterion variables (PCS, CPG Characteristic Pain Disability, CES-D, and 
Average Pain Intensity score). Three hierarchical multiple regression models (Model 1-3) were 
fitted to assess the extent to which the ChSOPA-14 scales were associated with concurrent 
criterion variables (depression, pain intensity, and disability) to test for the overall importance of 
pain-related beliefs as predictors of functioning, and identify those beliefs that contribute unique 
variance to the criterion variables. In each regression analysis, socio-demographic variables that 
were significant in univariate analyses (p<.05) were entered in the first block to control for their 
potential confounding effects. Two pain variables, including pain duration and number of pain 
sites, were entered in the second block, followed by PCS. The seven ChSOPA-14 scales were 
then entered in a final step. The dependent variables of pain intensity and disability were indexed 
by the CPG Characteristic Pain Intensity Score and Disability Score, respectively. Depression 
was indexed by the CES-D total score.  
 
Results 
Characteristics of the Chinese sample   
A total of 208 (of 218 eligible patients; 95% of patients approached) completed the 
interview and the questionnaires at baseline. The mean age of the sample was 40.95 (SD=11.28) 
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years and 54.3% were female. About 47.0% of the patients reported monthly household incomes 
of <HK$15,000 (US$1,923) and 55.9% were married or cohabited; 53.4% had completed 
secondary and 12.1% tertiary education. While 53.4% reported no particular religious belief, 
28.2% endorsed Buddhism, Daosim or ancestor worship. Over half (53.0%) of the patients 
reported being in full-time employment, whereas 16.5% and 11.7% respectively described 
themselves as unemployed or housewives.   
The pain characteristics of the sample are summarized in Table 1. This Chinese sample 
identified an average of 1.89 (SD=1.44; range, 1-11) pain sites, with 48.7% reporting multiple 
pain sites. The most common pain site was the leg (37.0%). Patients reported an average duration 
for their pain problem of 4.15 years (SD= 83, median=2.0, range, 3 months to 40 years). Over 
half (54.3%) had had pain for up to 2 year’s duration. The sample reported an average of 25.38 
days (SD=38.10; range, 0-90 days) of pain associated disability. The CPG classification placed 
52.5% of the sample as Grade III or above (high disability and moderately-to-severely limiting). 
The mean total scores of the PCS and CES-D were 29.00 (SD=14.30) and 17.99 (SD=14.06), 
respectively. 
[Insert Table 1 about here] 
 
Means, standard deviations, and correlations of SOPA-14 scales with criterion measures  
 Table 2 presents the means, standard deviations, and correlations of SOPA-14 scales with 
criterion variables. The Medical Cure (mean=2.98; SD=1.05) and Disability scales (mean=1.75; 
SD=1.67) obtained the highest and lowest means, probably reflecting were the most strongly and 
weakly endorsed pain attitudes respectively. Except Medical Cure (all p>0.05), all ChSOPA-14 
scales demonstrated significant correlation with the four criterion measures (all p<0.05). Pain 
Control consistently demonstrated negative correlations (rs≥0.30) with the criterion variables 
assessed (p<0.05).  
[Insert Table 2 about here] 
 
Multivariate prediction of concurrent chronic pain adjustment from the ChSOPA-14 scales in 
the Chinese sample 
 Table 3-5 report the results of hierarchical multiple regression analyses for the concurrent 
association between ChSOPA-14 scales and chronic pain adjustment outcomes in the current 
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Chinese sample. After controlling for socio-demographic and pain variables, both PCS 
(F(1,184)=92.48, p<.001) and ChSOPA-14 scales (F(7,177)=14.51, p<.001) contributed 
significantly to associations with concurrent depression (Table 3). ChSOPA-14 accounted for 
13% of the total variance in depression scores. Pain Control (stdβ =-.13; 95% CI: -3.41, -.13; 
p<.05) and Emotion (stdβ =.29; 95% CI: 1.76, 5.02; p<.001) emerged as significant independent 
(when controlling for other ChSOPA-14 scales) correlates of concurrent depression. After 
adjusting for sociodemographic and pain variables, only PCS (F(1,186)=12.60, p<.001) 
contributed significantly to associations with concurrent pain intensity (Table 4). When socio-
demographic and pain variables were controlled, both PCS (F(1,187)=13.67, p<.001) and 
ChSOPA-14 (F(7,180)=8.77, p<.001) contributed significantly to associations with concurrent 
disability (Table 5). The amount of unique variance explained by PCS and ChSOPA-14 were 
14% and 10% respectively. Of the 7 ChSOPA-14 scales, Disability (stdβ =.19, 95% CI: 1.33, 
7.88, p<.01), Emotion (stdβ =.16, 95% CI: .08, 7.59, p<.05), and Solicitude (stdβ =-.14, 95% CI: 
-7.05, -.04, p<.05) significantly associated with concurrent disability. 
 
[Insert Table 3-5 about here] 
 
DISCUSSION 
 This paper aimed to assess the construct and concurrent predictive validity of the Chinese 
version of the 14-item SOPA in a sample of Chinese patients with chronic pain. The findings 
offer preliminary evidence for the validity of the seven ChSOPA-14 scales as evidenced by its 
satisfactory univariate associations with pain catastrophizing, depression, pain disability and 
intensity measures in expected directions, and multivariate associations with the validity criterion.
 Belief in control over pain is generally viewed as adaptive, while believing that one is 
disabled or that chronic pain signals damage is not.3,20 Our sample more strongly endorsed a 
belief in their ability to control pain but more weakly endorsed the belief that they were disabled 
and in medication as the appropriate treatment strategy for pain as compared to previous reports 
in Western samples.4,21 By holding more adaptive pain beliefs, as measured by these domains, the 
Chinese sample would be expected to evidence better adjustment to pain than the US samples.4,21  
Compared to data reported in previous studies,4,21 the Medication scale score in this 
Chinese sample was lower, suggesting that Chinese patients may adopt of a Western medical 
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perspective when considering the Medication items; hence, a lower Medication score might 
indicate the Chinese sample was more interested in traditional Chinese medication, rather than 
disbelief in medication. Hong Kong’s mixed medical system ensures its Chinese patients are 
familiar with both Western as well as Chinese medical strategies, such as acupuncture. Most 
Hong Kong residents use both systems. Also, medication beliefs were positively associated with 
all criterion variables, most strongly with depression. Perhaps strong beliefs in the 
appropriateness of medication for pain treatment prompts over-reliance on medical treatment and 
reducing use of non-medical adaptive coping strategies, such as exercise or systematic relaxation, 
or greater engagement of avoidance behaviors, both of which may further impair physical, via 
disuse syndrome, and psychological functioning via depression, for example. While this study 
design prohibits determining interactions between pain cognition, pain coping strategies and their 
effects on pain adjustment outcomes the impact of relationships between pain beliefs and coping 
on pain adjustment has been described elsewhere.20  
Consistent with previous report,21 the associations between the Medical Cure scale and 
the criterion variables were not significant in this sample. This interesting consistency across 
cultures suggests that beliefs in medical cure may not influence adaptation and they are not 
important in both the Chinese and the Western culture. Yet, Chinese culture encourages sick role 
adoption, as higher SOPA Solicitude scale scores indicate, reflecting a stronger belief, relative to 
the Western samples, that family members adopt caretaking roles to family member patients. 
Overall, these findings suggest that self-management approaches to pain in Chinese patients may 
face more obstacles than among patients in Western countries.  Exploration of participation in 
self-management-oriented multidisciplinary treatment programs among patients from China and 
Western countries is warranted.  
The direction of relationship of the Emotion, Medication, and Solicitude scales with pain 
intensity in this Chinese sample was the opposite seen for the Western sample in previous study.4 
Among Chinese patients, greater Emotion, Medication and Solicitude scores were associated 
with greater pain intensity. This suggests help seeking may be more likely for Chinese, whereas 
the inverse relationships in the Western sample4 suggest a hopelessness-like response. These 
differential relationships between pain beliefs and perceptions suggest culture may predispose 
certain interpretive responses to pain experiences and, in turn influence adaptive reactions, 
reflecting Zbrowski’s early observations.22 This informs approaches to adapting CBT for treating 
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pain in Chinese patients. The specific beliefs, targeted in CBT intervention for Chinese patients, 
need to accommodate meaning differences in cultural backgrounds, such as shifting Chinese 
patients away from seeking unrealistic pain amelioration to self-management of their pain, to 
improve intervention effectiveness. 
 Pain catastrophizing predicted adjustment outcomes in all multivariate models we tested, 
consistent with Western population findings.20,23,24 Multivariate associations between the 
ChSOPA-14 scales and validity criteria provide preliminary evidence supporting the ChSOPA-
14’s concurrent predictive validity. After controlling for sociodemographic variables, pain history, 
and catastrophizing, ChSOPA-14 scales still accounted for 13% of the total variance in 
concurrent depression. In particular, Pain Control and Emotion were independently association 
with concurrent depression. Consistent with previous data,6 stronger Pain Control beliefs 
associated with decreased concurrent depressive mood (i.e., better mood). ChSOPA-14 scales 
accounted for 10% of the total variance in concurrent pain disability scores, primarily attributable 
to higher Disability and Emotion, but lower Solicitude scores, consistent with previous studies.7,8  
Our results should be interpreted in light of their limitations. First, our Chinese sample 
derived from a specialist orthopedics clinic. How generalizable ChSOPA-14 and these findings 
are to other pain populations within China and how comparable between the Chinese and the 
Western samples in previous reports4,21 given the different pain services they attended are unclear. 
However, because specialist services for chronic pain in Hong Kong are currently limited to eight 
multidisciplinary public hospital pain clinics, where most chronic pain patients are managed by 
orthopedics specialists, the applicability of the ChSOPA-14 likely remains high. Under the 
current public service model for pain management in Hong Kong, if pain patients attending 
orthopaedic clinic do not show any better in 1-2 years, they will be referred to pain clinic; by 
which time, patients’ pain, disability and psychiatric problems have already been present for 
some time or more common. Hence, the current Chinese sample attending orthopedics services 
are likely to represent the chronic pain population with presenting problems at an early stage of 
the chronic pain trajectories. Direct comparisons between the pain characteristics of the Chinese 
and Western samples and the extent to which differences on pain beliefs were arisen from 
differences on pain characteristics cannot be determined in this study. These issues should be 
addressed in future cross-cultural studies. Second, the ChSOPA-14 translation was used within a 
Cantonese-speaking context and assessed in Cantonese-speaking Hong Kong-Chinese. 
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Consequently, replication of the findings in other Chinese and Asian populations is needed. Third, 
the study’s cross-sectional design does not allow conclusions regarding causality. Future research 
should be conducted to explore non-linear, unidirectional relationships among ChSOPA-14 
scales, catastrophizing cognition, pain characteristics, and adjustment outcomes using analytic 
approaches such as structural equation and latent growth curve modeling in the context of 
randomized trials designed to alter pain beliefs, to help elucidate possible causal associations 
among these variables.  
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Table 1: Pain characteristics of the Hong Kong-Chinese sample  
Pain Characteristics % 





Pain site  
Head  2.9 
Neck  13.0 
Shoulder  20.7 
Hand 26.9 
Chest  1.9 
Upper back 9.1 
Low back  28.8 
Pelvis 13.5 
Knee 14.9 
Leg  37.0 
Joint  13.9 
Muscle  2.4 
Nerve 1.9 
Others 1.4 
Pain duration (years); M (SD) 4.15 (5.83) 
≥ 3 months - 2 years 54.3 
  > 2 years - 5 years 23.1 
  > 5 years - 10 years 14.4 
  > 10 years 8.2 
Pain intensitya; M (SD)  
Present pain 3.98 (2.70) 
Average pain 5.40 (2.16) 
Worst pain  7.54 (2.38) 
Pain interferenceb; M (SD)  
Daily activities 5.82 (2.98) 
Social activities 5.00 (3.40) 
Working ability 5.79 (3.36) 
Pain associated disability (days); M (SD) 25.38 (38.10) 
Chronic Pain Grade classificationc  
Grade Zero 0.5 
Grade I 24.0 
Grade II 23.0 
Grade III 26.5 
Grade IV 26.0 
PCS; M (SD) 29.00 (14.30) 
CES-D; M (SD) 17.99 (14.06) 
Note: Figures are percentages unless otherwise stated; The pain intensity and pain 
interference scores were drawn from individual items of the Chronic Pain Grade 
questionnaire. PCS: Pain Catastrophizing Scale; CES-D: Center for Epidemiological 
Studies – Depression Scale.  
a Scores range from 0-10; higher scores indicate higher intensity of pain. 
b Scores range from 0-10; higher scores indicate higher level of interference. 
c Grade Zero: Pain free; Grade I: low disability-low intensity; Grade II: low disability-
high intensity; Grade III: high disability-moderately limiting; Grade IV: high disability-
severely limiting. 
Table 2: Means and standard deviations of SOPA-14 scales in the US and Hong Kong-Chinese samples 
 
 
  Persaon’s Correlation  
Mean (SD) Catastrophizing 
Thinkinga 
Pain Disabilityb Depressionc Pain Intensityd 
Pain Control 2.32 (1.01)        -0.26**    -0.13*    -0.30**      -0.18* 
Disability 1.75 (1.67) 0.23**  0.35** 0.30** 0.21** 
Harm 2.53 (0.80) 0.26**  0.13* 0.23** 0.16* 
Emotion 2.36 (1.20) 0.54**  0.37** 0.54** 0.26** 
Medication 1.91 (1.35) 0.30**  0.27** 0.43** 0.25** 
Solicitude 2.51 (1.36) 0.40**  0.16** 0.28** 0.20** 
Medical Cure 2.98 (1.05) 0.05    -0.03    -0.08      -0.04 
Note: SOPA-14: The 14-item Survey of Pain Attitudes; SD: Standard deviation.  
a Indexed by the PCS; scores range from 0 to 52, with higher scores indicating more frequent pain catastrophizing thinking.  
b Indexed by the CPG Disability Score; scores range from 0-100 with higher scores indicating greater level of disability. 
c Indexed by the CES-D total score; scores range from 0-60 with higher scores indicating higher level of depressive symptoms.  
d Indexed by 0-10 NRS, 0-10 numerical rating scale of average pain intensity.  
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Table 3: Hierarchical multiple regression analyses predicting concurrent depression (CES-D scores) with ChSOPA-14 subscales in the 
Hong Kong-Chinese sample 
 
 Model 1: Depression 
Std β R2 ∆R2 ∆F 
1. Sociodemographic variables  0.08 0.08 5.50** 
Household income               -0.02    
Education level               -0.16**    
Employment status 0.09    
2. Pain variables   0.15 0.07 8.00*** 
Pain duration                -0.12*    
No. of pain site 0.07    
3. Pain catastrophizing thinking 0.27*** 0.39 0.23           70.47*** 
4. ChSOPA-14 subscales  0.52 0.13 6.66*** 
Pain Control                -0.13*    
Disability 0.08    
Harm 0.05    
Emotion 0.29***    
Medication 0.12    
Solicitude               -0.04    
Medical Cure               -0.09    
Note: Depression was indexed by the Center for Epidemiological Studies – Depression Scale; ChSOPA-14: The 14-Item Chinese Survey of Pain 
Attitudes; Std β: Standardized beta coefficient; SE: Standard error; CI: Confidence interval; ∆: Change. 
*p<0.05; **p<0.01; ***p<0.001.   
  
Table 4: Hierarchical multiple regression analyses predicting concurrent pain intensity with ChSOPA-14 subscales in the Hong Kong-
Chinese sample 
 
 Model 2: Pain Intensity 
Std β R2 ∆R2 ∆F 
1. Sociodemographic variables  0.12 0.12 6.60*** 
Gender 0.18**    
Age 0.04    
Education level                -0.20**    
Employment status 0.05    
2. Pain variables      
Pain duration                -0.18** 0.21 0.09           10.79*** 
No. of pain site 0.20**    
3. Pain catastrophizing thinking 0.25** 0.32 0.11           29.71*** 
4. ChSOPA-14 subscales  0.37 0.05 2.06 
Pain Control                -0.10    
Disability 0.07    
Harm 0.05    
Emotion 0.04    
Medication 0.10    
Solicitude               -0.03    
Medical Cure               -0.10    
Note: Pain intensity was indexed by the CPG Characteristic Pain Intensity Score, with scores ranging from 0-100 and higher scores indicating 
higher pain intensity; ChSOPA-14: The 14-Item Chinese Survey of Pain Attitudes; Std β: Standardized beta coefficient; SE: Standard error; CI: 
Confidence interval; ∆: Change. 
*p<0.05; **p<0.01; ***p<0.001.   
 
Table 5: Hierarchical multiple regression analyses predicting concurrent pain disability with ChSOPA-14 subscales in the Hong Kong-
Chinese sample 
 
 Model 3: Pain Disability 
Std β R2 ∆R2 ∆F 
1. Sociodemographic variables  0.05 0.05 4.74* 
Marital status 0.07    
Education level                -0.16*    
2. Pain variables   0.13 0.08 8.66 
Pain duration                 -0.23**    
No. of pain site 0.10    
3. Pain catastrophizing thinking 0.28*** 0.27 0.14           35.70*** 
4. ChSOPA-14 subscales  0.37 0.10 4.12*** 
Pain Control  0.01    
Disability 0.19**    
Harm                -0.05    
Emotion 0.16*    
Medication 0.13    
Solicitude                -0.14*    
Medical Cure                -0.08    
Note: Pain disability was indexed by the CPG Disability Score with scores ranging from 0-100 and higher scores indicating greater level of 
disability; ChSOPA-14: The 14-Item Chinese Survey of Pain Attitudes; Std β: Standardized beta coefficient; SE: Standard error; CI: Confidence 
interval; ∆: Change. 
*p<0.05; **p<0.01; ***p<0.001.   
 
